Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Annovis Bio Inc
ANVS
Healthcare
Biotechnology
Annovis Bio, Inc. is a clinical-stage drug platform company addressing neurodegeneration such as Alzheimer’s disease (AD), Parkinson’s disease (PD) and other chronic neurodegenerative diseases. The Company is developing its lead product candidate, Buntanetap, which is designed to address AD, PD, and potentially other chronic neurodegenerative diseases. Buntanetap is a synthetically produced...
small molecule, orally administered, brain penetrant compound. Its product candidate ANVS405 is an intravenous drug being developed for acute indications and focused on protecting the brain after traumatic brain injury (TBI) and/or stroke. ANVS405 is the same compound as Buntanetap, given in cases of acute head and brain trauma. ANVS301 is an orally administered drug being developed to increase cognitive capability in later stages of AD and dementia. ANVS301 is observed to improve memory and learning in very old rats by lowering the number of errors from six to three.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NYSE:ANVS)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
Next
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on May 21, 2021 1:38pm
ANVS......drop u beeatch !!!!!
Makin $'s to cover my UONE loss Drop hard
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on May 21, 2021 12:49pm
RE:ANVS...... dodge a bullet there
Harder....... Phase 2 results don't work for me
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on May 21, 2021 12:46pm
ANVS...... dodge a bullet there
now a $90 break Drop u madda pakka
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on May 21, 2021 12:34pm
ANVS..... I'm Short
Looking for a sharp decline Currently at $90
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on May 21, 2021 11:19am
ANVS....halted again
just another day on NASDAQ
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on May 21, 2021 11:18am
ANVS..... Back now
And a N.H.O.D
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on May 21, 2021 11:14am
ANVS.....Halted again
It will be back in 4 mins
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on May 21, 2021 11:13am
ANVS....wow
3rd tap on H.O.D
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on May 21, 2021 10:15am
ANVS...... Strike 1
In PB Mode has to hold ~ $52.00
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on May 21, 2021 10:08am
ANVS....huge runner on Ph 2 news
In PB mode Careful
Prev
1
2
3
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Learn How this Company is Disrupting Point-of-Care Testing
Why Dozens of Pro Athletes are Paying Attention to this Product
Do you want to stay ahead of the markets? See how DealRoom can help.
Debt-Free Cannabis Company Set for Next Stage of Growth
Growth Rocket 2025 – Why dynaCERT is in the Spotlight